232 related articles for article (PubMed ID: 31647573)
1. Therapeutic targets in myeloma bone disease.
Marino S; Petrusca DN; Roodman GD
Br J Pharmacol; 2021 May; 178(9):1907-1922. PubMed ID: 31647573
[TBL] [Abstract][Full Text] [Related]
2. Management of Myeloma Bone Lesions.
Du JS; Yen CH; Hsu CM; Hsiao HH
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806209
[TBL] [Abstract][Full Text] [Related]
3. Myeloma bone disease: pathogenesis, current treatments and future targets.
Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
[TBL] [Abstract][Full Text] [Related]
4. New agents in the Treatment of Myeloma Bone Disease.
Ring ES; Lawson MA; Snowden JA; Jolley I; Chantry AD
Calcif Tissue Int; 2018 Feb; 102(2):196-209. PubMed ID: 29098361
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for delivering drugs to bone.
Sun S; Tao J; Sedghizadeh PP; Cherian P; Junka AF; Sodagar E; Xing L; Boeckman RK; Srinivasan V; Yao Z; Boyce BF; Lipe B; Neighbors JD; Russell RGG; McKenna CE; Ebetino FH
Br J Pharmacol; 2021 May; 178(9):2008-2025. PubMed ID: 32876338
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.
Lee OL; Horvath N; Lee C; Joshua D; Ho J; Szer J; Quach H; Spencer A; Harrison S; Mollee P; Roberts AW; Talaulikar D; Brown R; Augustson B; Ling S; Jaksic W; Gibson J; Kalff A; Johnston A; Kalro A; Ward C; Prince HM; Zannettino A
Intern Med J; 2017 Aug; 47(8):938-951. PubMed ID: 28782211
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic targets in myeloma bone disease.
Webb SL; Edwards CM
Br J Pharmacol; 2014 Aug; 171(16):3765-76. PubMed ID: 24750110
[TBL] [Abstract][Full Text] [Related]
8. The role of bone-modifying agents in myeloma bone disease.
Lu H; Pundole X; Lee HC
JBMR Plus; 2021 Aug; 5(8):e10518. PubMed ID: 34368608
[TBL] [Abstract][Full Text] [Related]
9. Overview of treatment approaches to osteoporosis.
Langdahl BL
Br J Pharmacol; 2021 May; 178(9):1891-1906. PubMed ID: 32060897
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance.
Puppo M; Taipaleenmäki H; Hesse E; Clézardin P
Br J Pharmacol; 2021 May; 178(9):1936-1954. PubMed ID: 31423566
[TBL] [Abstract][Full Text] [Related]
11. Possible targets to treat myeloma-related osteoclastogenesis.
Bolzoni M; Toscani D; Storti P; Marchica V; Costa F; Giuliani N
Expert Rev Hematol; 2018 Apr; 11(4):325-336. PubMed ID: 29495905
[TBL] [Abstract][Full Text] [Related]
12. An Evidence-Based Approach to Myeloma Bone Disease.
Bingham N; Reale A; Spencer A
Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
[TBL] [Abstract][Full Text] [Related]
13. Emerging treatment approaches for myeloma-related bone disease.
Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of bisphosphonates in pain.
Tzschentke TM
Br J Pharmacol; 2021 May; 178(9):1973-1994. PubMed ID: 31347149
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of myeloma bone disease.
Esteve FR; Roodman GD
Best Pract Res Clin Haematol; 2007 Dec; 20(4):613-24. PubMed ID: 18070709
[TBL] [Abstract][Full Text] [Related]
16. Myeloma bone disease: pathogenesis and treatment.
O'Donnell EK; Raje NS
Clin Adv Hematol Oncol; 2017 Apr; 15(4):285-295. PubMed ID: 28591104
[TBL] [Abstract][Full Text] [Related]
17. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
18. Myeloma and Bone Disease.
Panaroni C; Yee AJ; Raje NS
Curr Osteoporos Rep; 2017 Oct; 15(5):483-498. PubMed ID: 28861842
[TBL] [Abstract][Full Text] [Related]
19. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.
Pennisi A; Ling W; Li X; Khan S; Wang Y; Barlogie B; Shaughnessy JD; Yaccoby S
PLoS One; 2010 Dec; 5(12):e15233. PubMed ID: 21188144
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options in the management of myeloma bone disease.
Berenson JR
Semin Oncol; 2010 Jun; 37 Suppl 1():S20-9. PubMed ID: 20682368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
